MiCo BioMed Co., Ltd. (XKON:A214610) announced a private placement of series 5 bearer's interest free non-guaranteed private equity bond for an aggregate gross proceeds of KRW 5,000,000,000 on October 14, 2019. The transaction will include participation from Lindman Asia Investment Cooperative No. 10. The bonds will carry no surface interest rate and maturity rate of interest of 1.5% per annum. The bonds will mature on October 28, 2022. The bonds are convertible into 761,035 shares at a conversion price of KRW 6,570 per share which represents 6.24% stake in the company. The conversion period will start at October 28, 2020 and ends at September 28, 2022. The transaction is expected to close on October 28, 2019. The transaction has been approved by the board of directors of the company.